MY ACCOUNT | NEWSLETTER |

Prevalence of genetic mutations in horses with muscle disease


Deleterious genetic variants are an important cause of skeletal muscle disease. Immunohistochemical evaluation of muscle biopsies is standard for the diagnosis of muscle disorders. The prevalence of alleles causing hyperkalemic periodic paralysis (HYPP), malignant hyperthermia (MH), polysaccharide storage myopathy 1 (PSSM1), glycogen branching enzyme deficiency (GBED), myotonia congenita (MC) and myosin heavy chain myopathy (MYHM) in horses with muscle disease is unknown. 

The research team reviewed archived slides processed for immunohistochemical analysis from 296 horses with muscle disease. Researchers also obtained clinical information on the horses. DNA isolated from stored muscle samples from these horses were genotyped for disease variants. 

Histological findings were classified as myopathic in 192, neurogenic in 41, and normal in 63 horses. A third of the population had alleles that explained disease which constituted 45% of the horses with confirmed histological myopathic process. Four of six muscle disease alleles were identified only in quarter horse breeds. 

The allele causing PSSM1 was detected in other breeds, and MC was not detected in these samples. The My allele, associated with susceptibility for MYHM, was the most common (62%) with homozygotes (16/27) presenting a more severe phenotype compared to heterozygotes (6/33). All cases with the MH allele were fatal upon triggering by anesthesia, stress or concurrent myopathy. 

To summarize, muscle histological and genetic analyses are essential in the investigation of muscle disease, since 10% of the horses with muscle disease and normal histology had a muscle disease causing genetic variant, and 63% of histologically confirmed muscle with alterations had no known genetic variants.

Monica Aleman, et al. “Prevalence of genetic mutations in horses with muscle disease from a neuromuscular disease laboratory.” J Equine Vet Sci. 2022 Sep 20; 104129.  doi: 10.1016/j.jevs.2022.104129.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Innovations in animal health: artificial intelligence-enhanced hematocrit analysis for rapid anemia detection in small ruminants

Like0
Dislike0

Drug dose and drug choice: Optimizing medical therapy for veterinary cancer

Like0
Dislike0

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients

Like0
Dislike0

NC State Student Creates Coloring Book to Help Children Picture Possibilities in Veterinary Medicine

Like0
Dislike0

UltiMed Expands Syringe Portfolio with Launch of UltiCare® VetRx General Syringes

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top